4. Как не умереть от рака ЖКТ

4. Как не умереть от рака ЖКТ

^{‹‹1››.} Liu PH, Wang JD, Keating NL. Expected years of life lost for six potentially preventable cancers in the United States. Prev Med. 2013;56(5):309–13.

^{‹‹2››.} Bertram JS, Kolonel LN, Meyskens FL. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 1987;47(11):3012–31.

^{‹‹3››.} Hasleton PS. The internal surface area of the adult human lung. J Anat. 1972;112(Pt 3):391–400.

^{‹‹4››.} Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307(5717):1920

^{‹‹5››.} What are the key statistics about colorectal cancer? American Cancer Society website. http://www.cancer. org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Accessed March 3, 2015.

^{‹‹6››.} What are the key statistics about pancreatic cancer? American Cancer Society website. http://www. cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-key-statistics. Accessed March 3, 2015.

^{‹‹7››.} American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.

^{‹‹8››.} What are the key statistics about colorectal cancer? American Cancer Society website. http://www.cancer. org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Accessed March 3, 2015.

^{‹‹9››.} American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.

^{‹‹10››.} Screening for Colorectal Cancer. US Preventive Ser vices Task Force website. http://www. uspreventiveservicestaskforce.org/Home/GetFile/1/467/colcancsumm/pdf. Accessed March 3, 2015.

^{‹‹11››.} International Monetary Fund. World Economic Outlook Database. http://bit.ly/1bNdlWu. April 2015. Accessed May 2, 2015.

^{‹‹12››.} World Bank. World Development Indicators. http://data.worldbank.org/country/india. 2011. Accessed May 2, 2015.

^{‹‹13››.} Bengmark S, Mesa MD, Gill A. Plant-derived health: the Effects of turmeric and curcuminoids. Nutr Hosp. 2009;24(3):273–81.

^{‹‹14››.} Hutchins-Wolfbrandt A, Mistry AM. Dietary turmeric potentially reduces the risk of cancer. Asian Pac J Cancer Prev. 2011;12(12):3169–73.

^{‹‹15››.} Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847–54.

^{‹‹16››.} Carroll RE, Benya RV, Turgeon DK, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011;4(3):354–64.

^{‹‹17››.} Cruz-Correa M, Shoskes DA, Sanchez P, et al. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006; 4(8): 1035–8.

^{‹‹18››.} Sharma RA, McLelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7(7):1894–900.

^{‹‹19››.} Singh S. From exotic spice to modern drug? Cell. 2007;130(5):765–8.

^{‹‹20››.} International Institute for Population Sciences & Macro International: National Family Health Survey (NFHS-3), 2005–06: India: Vol. I. Mumbai: IIPS; 2007.

^{‹‹21››.} Cummings JH, Bingham SA, Heaton KW, Eastwood MA. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology. 1992; 103(6): 1783–9.

^{‹‹22››.} Gear JS, Brodribb AJ, Ware A, Mann JI. Fibre and bowel transit times. Br J Nutr. 1981;45(1): 77–82.

^{‹‹23››.} Burkitt DP, Walker AR, Painter NS. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet. 1972;2(7792):1408–12.

^{‹‹24››.} Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci. 1989;34(4):606–11.

^{‹‹25››.} Burkitt DP. A deficiency of dietary fiber may be one cause of certain colonic and venous disorders. Am J Dig Dis. 1976;21(2):104–8.

^{‹‹26››.} Fox A, Tietze PH, Ramakrishnan K. Anorectal conditions: anal fi ssure and anorectal fi stula. FP Essent. 2014;419:20–7.

^{‹‹27››.} Burkitt DP. A deficiency of dietary fiber may be one cause of certain colonic and venous disorders. Am J Dig Dis. 1976;21(2):104–8.

^{‹‹28››.} Sanjoaquin MA, Appleby PN, Spencer EA, Key TJ. Nutrition and lifestyle in relation to bowel movement frequency: a cross-sectional study of 20630 men and women in EPIC-Oxford. Public Health Nutr. 2004;7(1):77–83.

^{‹‹29››.} What are the key statistics about colorectal cancer? American Cancer Society website. http://www. cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Accessed March 3, 2015.

^{‹‹30››.} Doll R. The geo graph i cal distribution of cancer. Br J Cancer. 1969;23(1):1–8.

^{‹‹31››.} Lipski E. Traditional non-Western diets. Nutr Clin Pract. 2010;25(6):585–93.

^{‹‹32››.} Burkitt DP. Epidemiology of cancer of the colon and rectum.1971. Dis. Colon Rectum. 1993; 36(11): 1071–82.

^{‹‹33››.} Shaper AG, Jones KW. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959. Int J Epidemiol. 2012;41(5):1221–5.

^{‹‹34››.} Malila N, Hakulinen T. Epidemiological trends of colorectal cancer in the Nordic countries. Scand J Surg. 2003;92(1):5–9.

^{‹‹35››.} Englyst HN, Bingham SA, Wiggins HS, et al. Nonstarch polysaccharide consumption in four Scandinavian populations. Nutr Cancer. 1982;4(1):50–60.

^{‹‹36››.} Graf E, Eaton JW. Dietary suppression of colonic cancer. Fiber or phytate? Cancer. 1985; 56(4): 717–8.

^{‹‹37››.} Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk— a systematic review and metaanalysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23(1): 12–31.

^{‹‹38››.} Mellanby E. The rickets-producing and anti-calcifying action of phytate. J Physiol. 1949; 109(3–4):488–533.

^{‹‹39››.} House WA, Welch RM, Van Campen DR. Effect of phytic acid on the absorption, distribution, and endogenous excretion of zinc in rats. J Nutr. 1982;112(5):941–53.

^{‹‹40››.} Urbano G, L?pez-Jurado M, Aranda P, Vidal-Valverde C, Tenorio E, Porres J. The role of phytic acid in legumes: antinutrient or benefi cial function? J Physiol Biochem. 2000;56(3):283–94.

^{‹‹41››.} L?pez-Gonz?lez AA, Grases F, Roca P, Mari B, Vicente-Herrero MT, Costa-Bauz? A. Phytate (myo- inositol hexaphosphate) and risk factors for osteoporosis. J Med Food. 2008;11(4): 747–52.

^{‹‹42››.} L?pez-Gonz?lez AA, Grases F, Monroy N, et al. Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women. Eur J Nutr. 2013;52(2): 717–26.

^{‹‹43››.} Arriero Mdel M, Ramis JM, Perell? J, Monjo M. Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts. PLoS ONE. 2012;7(8):e43187.

^{‹‹44››.} Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007; 22(10):1479–91.

^{‹‹45››.} Singh PN, Fraser GE. Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol. 1998;148(8):761–74.

^{‹‹46››.} Manousos O, Day NE, Trichopoulos D, Gerovassilis F, Tzonou A, Polychronopoulou A. Diet and colorectal cancer: A case-control study in Greece. Int J Cancer. 1983;32(1):1–5.

^{‹‹47››.} Lanza E, Hartman TJ, Albert PS, et al. High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial. J Nutr. 2006; 136(7):1896–1903.

^{‹‹48››.} Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer. 2006;55(2):109–25.

^{‹‹49››.} Vucenik I, Shamsuddin AM. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr. 2003;133(11-Suppl-1):3778S–84S.

^{‹‹50››.} Ogawa S, Kobayashi H, Amada S, et al. Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol. 2010;15(1):52–8.

^{‹‹51››.} Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer. 2006;55(2):109–25.

^{‹‹52››.} Vucenik I, Passaniti A, Vitolo MI, Tantivejkul K, Eggleton P, Shamsuddin AM. Anti-angiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis. 2004;25(11):2115–23.

^{‹‹53››.} Wang H, Khor TO, Shu L, et al. Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med Chem. 2012; 12(10): 1281–305.

^{‹‹54››.} Yang GY, Shamsuddin AM. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Anticancer Res. 1995;15 (6B): 2479–87.

^{‹‹55››.} Shamsuddin AM, Yang GY, Vucenik I. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res. 1996;16(6A): 3287–92.

^{‹‹56››.} Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I, Shamsuddin AM. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res. 1998;18(6A):4083–90.

^{‹‹57››.} Shamsuddin AM, Yang GY. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis. 1995;16(8):1975–9.

^{‹‹58››.} Shamsuddin AM. Anti-cancer function of phytic acid. Int J Food Sci Tech. 2002;37(7):769–82.

^{‹‹59››.} Sun J, Chu YF, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem. 2002;50(25):7449–54.

^{‹‹60››.} Olsson ME, Andersson CS, Oredsson S, Berglund RH, Gustavsson KE. Antioxidant levels and inhibition of cancer cell proliferation in vitro by extracts from organically and conventionally cultivated strawberries. J Agric Food Chem. 2006;54(4):1248–55.

^{‹‹61››.} Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal antiinflammatory drugs: nested case-control study. Lancet. 2005;365(9458):475–81.

^{‹‹62››.} Wang LS, Burke CA, Hasson H, et al. A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev Res (Phila). 2014;7(7): 666–74.

^{‹‹63››.} Wang LS, Burke CA, Hasson H, et al. A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev Res (Phila). 2014;7(7): 666–74.

^{‹‹64››.} Pan A, Sun Q, Bernstein AM, et al. Red meat consumption and mortality: Results from 2 prospective cohort studies. Arch Intern Med. 2012;172(7):555–63.

^{‹‹65››.} Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169(6):562–71.

^{‹‹66››.} Popkin BM. Reducing meat consumption has multiple benefits for the world’s health. Arch Intern Med. 2009;169(6):543.

^{‹‹67››.} Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10(1):9–17.

^{‹‹68››.} Hurrell R, Egli I. Iron bioavailability and dietary reference values. Am J Clin Nutr. 2010;91(5): 1461S–7S.

^{‹‹69››.} Cook JD. Adaptation in iron metabolism. Am J Clin Nutr. 1990;51(2):301–8.

^{‹‹70››.} Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk— a systematic review and metaanalysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23(1):12–31.

^{‹‹71››.} Yang W, Li B, Dong X, et al. Is heme iron intake associated with risk of coronary heart disease? A meta-analysis of prospective studies. Eur J Nutr. 2014;53(2):395–400.

^{‹‹72››.} Bao W, Rong Y, Rong S, Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med. 2012;10:119.

^{‹‹73››.} Zacharski LR, Chow BK, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008;100(14):996–1002.

^{‹‹74››.} Edgren G, Nyr?n O, Melbye M. Cancer as a ferrotoxic disease: are we getting hard stainless evidence? J Natl Cancer Inst. 2008;100(14):976–7.

^{‹‹75››.} Corpet DE. Red meat and colon cancer: should we become vegetarians, or can we make meat safer? Meat Sci. 2011;89(3):310–6.

^{‹‹76››.} Farmer B, Larson BT, Fulgoni VL 3rd, Rainville AJ, Liepa GU. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the national health and nutrition examination survey 1999–2004. J Am Diet Assoc. 2011;111(6):819–27.

^{‹‹77››.} Iron deficiency— United States, 1999–2000. MMWR Morb Mortal Wkly Rep. 2002;51(40): 897–9.

^{‹‹78››.} Craig WJ, Mangels AR. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009;109(7):1266–82.

^{‹‹79››.} Tiwari AK, Mahdi AA, Chandyan S, et al. Oral iron supplementation leads to oxidative imbalance in anemic women: a prospective study. Clin Nutr. 2011;30(2):188–93.

^{‹‹80››.} Saunders AV, Craig WJ, Baines SK, Posen JS. Iron and vegetarian diets. Med J Aust. 2013;199(4 Suppl): S11–6.

^{‹‹81››.} American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.

^{‹‹82››.} Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008;393(4):535–45.

^{‹‹83››.} Kolodecik T, Shugrue C, Ashat M, Thrower EC. Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol. 2013;4:415.

^{‹‹84››.} Thi?baut AC, Jiao L, Silverman DT, et al. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst. 2009;101(14):1001–11.

^{‹‹85››.} Landrigan PJ. Preface. Ann N Y Acad Sci. 1991;643:xv — xvi.

^{‹‹86››.} Weiner R, Rees D, Lunga FJ, Felix MA. Third wave of asbestos-related disease from secondary use of asbestos. A case report from industry. S Afr Med J. 1994;84(3):158–60.

^{‹‹87››.} Johnson ES, Zhou Y, Lillian Yau C, et al. Mortality from malignant diseases-update of the Baltimore union poultry cohort. Cancer Causes Control. 2010;21(2):215–21.

^{‹‹88››.} Felini M, Johnson E, Preacely N, Sarda V, Ndetan H, Bangara S. A pilot case-cohort study of liver and pancreatic cancers in poultry workers. Ann Epidemiol. 2011;21(10):755–66.

^{‹‹89››.} Lynch SM, Vrieling A, Lubin JH, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009;170(4): 403–13.

^{‹‹90››.} Rohrmann S, Linseisen J, N?thlings U, et al. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2013;132(3):617–24.

^{‹‹91››.} Rohrmann S, Linseisen J, Jakobsen MU, et al. Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011; 128(3):623–34.

^{‹‹92››.} Lotti M, Bergamo L, Murer B. Occupational toxicology of asbestos-related malignancies. Clin Toxicol (Phila). 2010;48(6):485–96.

^{‹‹93››.} Marvisi M, Balzarini L, Mancini C, Mouzakiti P. A new type of hypersensitivity pneumonitis: salami brusher’s disease. Monaldi Arch Chest Dis. 2012;77(1):35–7.

^{‹‹94››.} Yang ZY, Yuan JQ, Di MY, et al. Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis. PLoS ONE. 2013;8(3):e57528.

^{‹‹95››.} Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer. 2004;101(10):2351–62.

^{‹‹96››.} Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14(14):4491–9.

^{‹‹97››.} Bosetti C, Bravi F, Turati F, et al. Nutrient-based dietary patterns and pancreatic cancer risk. Ann Epidemiol. 2013;23(3):124–8.

^{‹‹98››.} Mills PK, Beeson WL, Abbey DE, Fraser GE, Phillips RL. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer. 1988;61(12):2578–85.

^{‹‹99››.} American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.

^{‹‹100››.} Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24(2):301–8.

^{‹‹101››.} Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43(1):1–14.

^{‹‹102››.} Lagergren J, Bergstr?m R, Lindgren A, Nyr?n O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825–31.

^{‹‹103››.} Pohl H, Welch HG. The role of overdiagnosis and reclassifi cation in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–6.

^{‹‹104››.} Parasa S, Sharma P. Complications of gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2013;27(3):433–42.

^{‹‹105››.} El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5(1):17–26.

^{‹‹106››.} De Ceglie A, Fisher DA, Filiberti R, Blanchi S, Conio M. Barrett’s esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet. Clin Res Hepatol Gastroenterol. 2011;35(1):7–16.

^{‹‹107››.} Navarro Silvera SA, Mayne ST, Risch H, et al. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer. 2008;123(4):852–60.

^{‹‹108››.} Nebel OT, Castell DO. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology. 1972;63(5):778–83.

^{‹‹109››.} Becker DJ, Sinclair J, Castell DO, Wu WC. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol. 1989;84(7):782–6.

^{‹‹110››.} Charlton KE, Tapsell LC, Batterham MJ, et al. Pork, beef and chicken have similar effects on acute satiety and hormonal markers of appetite. Appetite. 2011;56(1):1–8.

^{‹‹111››.} Mitsukawa T, Takemura J, Ohgo S, et al. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol. 1990;85(8):981–5.

^{‹‹112››.} Matsuki N, Fujita T, Watanabe N, et al. Lifestyle factors associated with gastroesophageal reflux disease in the Japanese population. J Gastroenterol. 2013;48(3):340–9.

^{‹‹113››.} Jung JG, Kang HW, Hahn SJ, et al. Vegetarianism as a protective factor for reflux esophagitis: a retrospective, cross-sectional study between Buddhist priests and general population. Dig Dis Sci. 2013;58(8):2244–52.

^{‹‹114››.} Fashner J, Gitu AC. Common gastrointestinal symptoms: risks of long-term proton pump inhibitor therapy. FP Essent. 2013;413:29–39.

^{‹‹115››.} Terry P, Lagergren J, Ye W, Nyr?n O, Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer. 2000;87(5):750–4.

^{‹‹116››.} Ekstr?m AM, Serafini M, Nyr?n O, Hansson LE, Ye W, Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case- control study in Sweden. Int J Cancer. 2000;87(1):133–40.

^{‹‹117››.} Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004;53(12):1730–5.

^{‹‹118››.} Coleman HG, Murray LJ, Hicks B, et al. Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. Nutr Rev. 2013;71(7): 474–82.

^{‹‹119››.} Burkitt DP. Hiatus hernia: is it preventable? Am J Clin Nutr. 1981;34(3):428–31.

^{‹‹120››.} Burkitt DP, James PA. Low-residue diets and hiatus hernia. Lancet. 1973;2(7821):128–30.

^{‹‹121››.} Burkitt DP, James PA. Low-residue diets and hiatus hernia. Lancet. 1973;2(7821):128–30.

^{‹‹122››.} Burkitt DP. Two blind spots in medical knowledge. Nurs Times. 1976;72(1):24–7.

^{‹‹123››.} Burkitt DP. Hiatus hernia: is it preventable? Am J Clin Nutr. 1981;34(3):428–31.

^{‹‹124››.} American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.

^{‹‹125››.} Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003;105(1):98–100.

^{‹‹126››.} Chen T, Yan F, Qian J, et al. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res (Phila). 2012;5(1): 41–50.

^{‹‹127››.} Chen T, Yan F, Qian J, et al. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res (Phila). 2012;5(1): 41–50.

^{‹‹128››.} Eaton SB, Konner M, Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med. 1988;84(4):739–49.

^{‹‹129››.} King DE, Mainous AG, Lambourne CA. Trends in dietary fiber intake in the United States, 1999–2008. J Acad Nutr Diet. 2012;112(5):642–8.

^{‹‹130››.} Zhang N, Huang C, Ou S. In vitro binding capacities of three dietary fibers and their mixture for four toxic elements, cholesterol, and bile acid. J Hazard Mater. 2011;186(1):236–9.

^{‹‹131››.} Moshfegh A, Goldman J, Cleveland l. What We Eat in America, NHANES 2001–2002: Usual Nutrient Intakes from Food Compared to Dietary Reference Intakes. Washington, D.C.: US Department of Agriculture Agricultural Research Ser vice; 2005.